Drug-drug-interaction Study to Assess the Effect of Darolutamide on the Pharmacokinetics of Probe Substrates of CYP3A4 and P-gp in Healthy Male Volunteers

NCT03237416 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostatic Neoplasms

Interventions

DRUG: Dabigatran etexilate
DRUG: Midazolam
DRUG: BAY1841788 (darolutamide)

Sponsor

Bayer

Collaborators

[object Object]